top of page

Latest News

Jul 21, 2024

Liv Labs Awarded Phase II Continuation SBIR Grant by the NIH

Liv Labs has been awarded a third Small Business Innovation Research (SBIR) grant to support development of a novel continence pessary intended to treat stress urinary incontinence (SUI) without a prescription. This continuation funding, from...

Tim McKeown - high res_edited.jpg

Jul 9, 2024

Liv Labs Joins AgeTech Atlanta with Inaugural Startup Scholarship

Liv Labs is proud to establish a presence in Atlanta and join AgeTech Atlanta in the important mission of improving the lives of older adults through technology and innovation. The expanded AgeTech Atlanta entrepreneurial space...

Tim McKeown - high res_edited.jpg

Jun 9, 2024

Atlanta Journal-Constitution Features Liv Labs

Liv Labs Inc., a consumer healthtech company making innovative solutions for urinary incontinence, was recently featured on the front page of Aging in...

Tim McKeown - high res_edited.jpg

Sep 15, 2023

Liv Labs Chosen for Springboard Enterprises 2023 Digital Health Innovation Cohort

Liv Labs Inc., a consumer healthtech company making solutions for urinary incontinence, is pleased to have been selected for a highly-coveted slot in the Springboard Enterprises 2023 Digital Health Innovation Cohort. Liv Labs joins...

Tim McKeown - high res_edited.jpg

Feb 14, 2023

First Study Participant Enrolled in Clinical Trial of Self-Managed SUI Pessary

Liv Labs Inc., a consumer healthtech company making solutions for urinary incontinence, announces that on February 13, 2023 the first study participant enrolled in the Pippa Pessary Study, a pivotal clinical trial to evaluate the...

Tim McKeown - high res_edited.jpg

Dec 5, 2022

Liv Labs Welcomes Pelvic Health Expert to Leadership Team

Liv Labs Inc., a venture-backed consumer healthtech company, welcomes Melissa Stendahl, PT, DPT to leadership team.

Tim McKeown - high res_edited.jpg

Dec 5, 2022

Liv Labs Selected for MATTER’s Inaugural 51 Labs Menopause Accelerator

Liv Labs Inc. joins the inaugural cohort of 51 Labs, sponsored by MATTER, the premier healthcare incubator and innovation hub, alongside Astellas Pharma US, Walgreens, BayCare, Parkview Health, University of Chicago Medicine and Capita3​​.

Tim McKeown - high res_edited.jpg

Apr 19, 2022

Liv Labs Awarded Competitive Digital Health Innovation Grant from the NSF

Liv Labs has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development (R&D) work on. . .

Tim McKeown - high res_edited.jpg

Dec 2, 2021

Liv Labs Recruits Wilson Sporting Goods Exec to Lead Product

Liv Labs Inc., a venture-backed consumer healthtech company, announces the appointment of Tim McKeown to the position of Vice President, Product and Commercialization. McKeown has decades of experience leading...

Tim McKeown - high res_edited.jpg

Aug 30, 2021

Silcon Valley's Y Combinator Backs Liv Labs

Liv Labs Inc. announces venture backing from Silicon Valley VC, Y Combinator. YC is reputed to have a talent for spotting high-potential, high-growth startups early...

Tim McKeown - high res_edited.jpg

Apr 12, 2021

NIH Awards Liv Labs $1.67M Research & Development Grant

Liv Labs gratefully announces an investment of non-dilutive governmental funding from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. These funds are part of...

Tim McKeown - high res_edited.jpg

> Read More
Tim McKeown - high res_edited.jpg

> Read More
Tim McKeown - high res_edited.jpg
bottom of page